세부전공

만성간질환, 알코올성 간질환, 만성간질환

질환군

바이러스성 간염 (B형간염,C형간염), 알코올성 지방간, 알코올성 간염, 비알코올성 지방간, 자가면역성 질환

증상군

피로감, 황달, 간수치 상승, 전신 쇄약

이영선 교수의 진료시간표

이영선 교수의 상세정보

• 2000 .03  ~  2006 .02  :  고려대학교 의과대학, 학사
• 2008 .09  ~  2010 .08  :  고려대학교 의과대학 의학과 내과학 석사
• 2011 .02  ~  2015 .02  :  한국과학기술원 (KAIST) 의과학대학원 이학 박사

• 2006 .03  ~  2007 .02  :  고대의료원, 수련의
• 2007 .03  ~  2011 .02  :  고대구로병원 내과, 전공의
• 2015 .03  ~  2017 .02  :  고대구로병원 소화기내과, 임상강사
• 2017 .03  ~  2018 .08  :  고대구로병원 소화기내과(간센터), 임상조교수
• 2019 .08  ~   :  고대구로병원 소화기내과(간센터), 조교수

• 2008  :  고대구로병원, 친절직원 우수상
• 2009  :  고대의료원, 의료원 개원기념모범직원 표창
• 2013  :  대한분자세포생물학회 (KSMCB) Excellent poster Award
• 2014  :  한국세포생물학회 (KSCB) Best publication Award
• 2014  :  대한간학회 The liver week 2014 Best Presentation Award, Free Paper
• 2015  :  대한간학회 The liver week 2015 Best Presentation Award, Plenary
• 2016  :  대한간학회 The liver week 2016 Best Presentation Award, Poser Oral
• 2016  :  The Gilead Sciences Research Scholars Program in Liver Disease - Asia
• 2018  :  우수 논문상. 고려대학교 의과대학 교우회
• 2018  :  APDW Rising star program-Liver

• 2010 .06  ~   :  대한간학회 정회원
• 2015 .06  ~   :  대한간암학회 정회원
• 2017 .07  ~  2018 .06  :  대한간암학회 보험위원
• 2018 .07  ~  2019 .06  :  대한간암학회 학술위원
• 2019 .07  ~  2020 .06  :  대한간암학회 기획위원
• 2019 .11  ~   :  현재 대한간학회 학술위윈 겸 간행위원

• [SCI] (Multiparametric MR Index for the Diagnosis of Non-Alcoholic Steatohepatitis in Patients with Non-Alcoholic Fatty Liver Disease.)
• [SCI] (Multiplexed Proteomic Approach for Identification of Serum Biomarkers in Hepatocellular Carcinoma Patients with Normal AFP.)
• [SCI] (Multiparametric MR Is a Valuable Modality for Evaluating Disease Severity of Nonalcoholic Fatty Liver Disease.)
• [SCI] (Reply)
• [SCI] (Reply)
• [SCI] (Underlying nonalcoholic fatty liver disease is a significant factor for breast cancer recurrence after curative surgery.)
• [SCI] (Role of tenofovir disoproxil fumarate in prevention of perinatal transmission of hepatitis B virus from mother to child: a systematic review and meta-analysis.)
• [SCI] (Hepatic resection compared to chemoembolization in intermediate- to advanced-stage hepatocellular carcinoma: A meta-analysis of high-quality studies.)
• [SCI] (Loss of toll-like receptor 3 aggravates hepatic inflammation but ameliorates steatosis in mice.)
• [SCI] (CX(3)CR1 differentiates F4/80(low) monocytes into pro-inflammatory F4/80(high) macrophages in the liver.)
• [SCI] (Can More Aggressive Treatment Improve Prognosis in Patients with Hepatocellular Carcinoma? A Direct Comparison of the Hong Kong Liver Cancer and Barcelona Clinic Liver Cancer Algorithms)
• [SCI] (Systematic review with meta-analysis: the efficacy and safety of tenofovir to prevent mother-to-child transmission of hepatitis B virus.)
• [SCI] (Exosomes derived from palmitic acid-treated hepatocytes induce fibrotic activation of hepatic stellate cells)
• [SCI] (Systematic review with meta-analysis: The Efficacy and Safety of Tenofovir to Prevent Mother-to-Child Transmission of Hepatitis B Virus)
• [SCI] (Treatment of Severe Alcoholic Hepatitis With Corticosteroid, Pentoxifylline, or Dual Therapy: A Systematic Review and Meta-Analysis)
• [SCI] (Hepatic immunophenotyping for streptozotocin-induced hyperglycemia in mice)
• [SCI] (Blockade of Retinol Metabolism Protects T Cell-Induced Hepatitis by Increasing Migration Blockade of Retinol Metabolism Protects T Cell-Induced Hepatitis by Increasing Migration of Regulatory T Cells)

최종수정일 : 2021.03.11